MLchartDataset catalogue

tyrosine kinase inhibitor OSI-930

Term · Oncology and biomedicine · MLC-T-ONC-017379

A selective thiophene-derived tyrosine kinase inhibitor with potential antineoplastic activity. Tyrosine kinase inhibitor OSI-930 inhibits stem cell factor receptor (c-Kit) and the vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of both tumor cell proliferation and tumor angiogenesis. Both c-Kit and VEGFR2 are overexpressed in a variety of cancers.

Table 1. Record
IdentifierMLC-T-ONC-017379
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017379",
  "term": "tyrosine kinase inhibitor OSI-930",
  "field": "Oncology and biomedicine",
  "definition": "A selective thiophene-derived tyrosine kinase inhibitor with potential antineoplastic activity. Tyrosine kinase inhibitor OSI-930 inhibits stem cell factor receptor (c-Kit) and the vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of both tumor cell proliferation and tumor angiogenesis. Both c-Kit and VEGFR2 are overexpressed in a variety of cancers.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tyrosine-kinase-inhibitor-osi-930/"
}

Record 16,876 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.